BetaThis is a new service - your feedback will help us to improve it.
Information
Changes to dashboard update frequency over the festive period
Some of the metrics will be updated on Wednesday 24 December at 2pm. The dashboard will not be updated the following week commencing Monday 29 December. Normal updates will resume for all metrics in the new year on Thursday 8 January at 4pm. More info.
Entry title:
Lead exposure in children
Last updated on Monday, 22 December 2025 at 12:54pm
Lead is a persistent heavy metal environmental contaminant that adversely affects health, even at low blood lead concentrations. There is no known safe threshold for lead exposure. Children and the foetus (thus pregnant women) are particularly vulnerable to the health impacts of lead exposure.
Lead Exposure in Children Surveillance System (LEICSS) is a passive surveillance system that notifies the Health Protection Teams (HPTs) of laboratory reports of elevated blood lead levels in children aged 0 to 15 years in England. This system facilitates effective health protection case management which primarily involves identifying and removing the individual from the source(s) of lead. Since 5 July 2021, the case definition for surveillance changed to half the original concentration, from 0.48 μmol/L (equivalent to ≥10μg/dL) to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Cases recorded by LEICSS come from several sources. The majority are reported directly to LEICSS by UK Accreditation Service (UKAS) accredited testing biochemistry or toxicology laboratories. These are then processed by LEICSS, recorded in the UKHSA case management system (CIMS) and referred to the HPT of residence for case management. A smaller number of cases of elevated blood lead are notified directly to Health Protection Teams (HPT), for example via the clinician caring for the child.
Annual reports are published each year to provide insights into the prevailing trends in case numbers and characteristics. This data will next be updated in winter 2025.
Counts of LEICSS cases reported by year. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Cases by year data for counts of LEICSS cases reported by year. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Figures are annual, but shown as at December of each year. For example, the figures for 2023 are shown as at "Dec 2023".
Up to and including 31 December 2024
Year
Number of cases
31 Dec 2024
247.00
31 Dec 2023
226.00
31 Dec 2022
191.00
31 Dec 2021
121.00
31 Dec 2020
35.00
31 Dec 2019
36.00
31 Dec 2018
45.00
31 Dec 2017
49.00
31 Dec 2016
33.00
31 Dec 2015
33.00
Download
About
NOTES:
A case is defined as a child with a blood lead concentration ≥0.24 μmol/L (equivalent to ≥5 μg/dL) detected in a UK Accreditation Service (UKAS) accredited biochemistry or toxicology laboratory. This is reported to UKHSA for public health intervention. The child is aged under 16 years at the time elevated levels of lead are detected in the blood and resident of England.
Prior to 5 July 2021, the case definition for surveillance was 0.48 μmol/L (equivalent to ≥10μg/dL).
Since 5 July 2021, the case definition for surveillance changed to half the original concentration to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Cases by UKHSA Region
The number of LEICSS cases reported across the nine UKHSA regions on England. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2024 are shown as at "Dec 2024"
Cases by UKHSA Region data for the number of LEICSS cases reported across the nine UKHSA regions on England. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2024 are shown as at "Dec 2024"
Up to and including 31 December 2024
Year
East of England
East Midlands
31 Dec 2024
8.00
8.00
31 Dec 2023
10.00
13.00
31 Dec 2022
6.00
10.00
31 Dec 2021
4.00
0.00
31 Dec 2020
4.00
3.00
31 Dec 2019
3.00
1.00
31 Dec 2018
4.00
3.00
31 Dec 2017
2.00
0.00
31 Dec 2016
5.00
0.00
31 Dec 2015
3.00
1.00
Year
West Midlands*
London*
31 Dec 2024
22.00
43.00
31 Dec 2023
30.00
30.00
31 Dec 2022
38.00
24.00
31 Dec 2021
11.00
20.00
31 Dec 2020
2.00
4.00
31 Dec 2019
0.00
11.00
31 Dec 2018
4.00
12.00
31 Dec 2017
3.00
10.00
31 Dec 2016
3.00
7.00
31 Dec 2015
2.00
5.00
Year
South East*
South West*
31 Dec 2024
15.00
20.00
31 Dec 2023
23.00
16.00
31 Dec 2022
10.00
9.00
31 Dec 2021
7.00
9.00
31 Dec 2020
0.00
3.00
31 Dec 2019
1.00
2.00
31 Dec 2018
3.00
4.00
31 Dec 2017
4.00
2.00
31 Dec 2016
0.00
0.00
31 Dec 2015
6.00
2.00
Year
North West
North East
31 Dec 2024
27.00
7.00
31 Dec 2023
18.00
8.00
31 Dec 2022
26.00
3.00
31 Dec 2021
11.00
5.00
31 Dec 2020
5.00
2.00
31 Dec 2019
4.00
0.00
31 Dec 2018
3.00
0.00
31 Dec 2017
11.00
1.00
31 Dec 2016
6.00
0.00
31 Dec 2015
4.00
1.00
Year
Yorkshire and Humber*
31 Dec 2024
97.00
31 Dec 2023
78.00
31 Dec 2022
65.00
31 Dec 2021
54.00
31 Dec 2020
12.00
31 Dec 2019
14.00
31 Dec 2018
12.00
31 Dec 2017
16.00
31 Dec 2016
12.00
31 Dec 2015
9.00
Download
About
NOTES:
A case is defined as a child with a blood lead concentration ≥0.24 μmol/L (equivalent to ≥5 μg/dL) detected in a UK Accreditation Service (UKAS) accredited biochemistry or toxicology laboratory. This is reported to UKHSA for public health intervention. The child is aged under 16 years at the time elevated levels of lead are detected in the blood and resident of England.
Prior to 5 July 2021, the case definition for surveillance was 0.48 μmol/L (equivalent to ≥10μg/dL).
Since 5 July 2021, the case definition for surveillance changed to half the original concentration to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
Average detection rates by UKHSA Region
The rate of LEICSS cases reported across the nine UKHSA regions in England. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2024 are shown as at "Dec 2024".
Average detection rates by UKHSA Region data for the rate of LEICSS cases reported across the nine UKHSA regions in England. A change in case definition since 2021 has led to a steep increase in the number of cases being reported. Regions with participating laboratories are denoted with an asterisk (*) in the legend below. Figures are annual, but shown as at December of each year. For example, the figures for 2024 are shown as at "Dec 2024".
Up to and including 31 December 2024
Year
East of England
East Midlands
31 Dec 2024
6.50
8.80
31 Dec 2023
8.22
14.42
31 Dec 2022
5.10
11.40
31 Dec 2021
3.10
0.00
31 Dec 2020
3.10
3.30
31 Dec 2019
2.40
1.10
31 Dec 2018
3.20
3.40
31 Dec 2017
1.60
0.00
31 Dec 2016
4.10
0.00
31 Dec 2015
2.50
1.20
Year
West Midlands*
London*
31 Dec 2024
18.60
25.40
31 Dec 2023
25.49
17.74
31 Dec 2022
33.10
14.20
31 Dec 2021
9.40
10.80
31 Dec 2020
1.70
2.20
31 Dec 2019
0.00
6.00
31 Dec 2018
3.40
6.50
31 Dec 2017
2.60
5.50
31 Dec 2016
2.60
3.90
31 Dec 2015
1.80
2.80
Year
South East*
South West*
31 Dec 2024
8.50
20.50
31 Dec 2023
13.05
16.41
31 Dec 2022
5.80
9.30
31 Dec 2021
4.10
9.10
31 Dec 2020
0.00
3.00
31 Dec 2019
0.60
2.00
31 Dec 2018
1.80
4.10
31 Dec 2017
2.40
2.00
31 Dec 2016
0.00
0.00
31 Dec 2015
3.60
2.10
Year
North West
North East
31 Dec 2024
19.00
14.70
31 Dec 2023
12.67
16.87
31 Dec 2022
18.70
6.40
31 Dec 2021
7.80
10.50
31 Dec 2020
3.60
4.20
31 Dec 2019
8.40
0.00
31 Dec 2018
2.20
0.00
31 Dec 2017
8.00
2.10
31 Dec 2016
4.40
0.00
31 Dec 2015
3.00
2.20
Year
Yorkshire and Humber*
31 Dec 2024
93.80
31 Dec 2023
75.48
31 Dec 2022
63.80
31 Dec 2021
51.40
31 Dec 2020
11.40
31 Dec 2019
13.30
31 Dec 2018
11.50
31 Dec 2017
15.40
31 Dec 2016
11.70
31 Dec 2015
8.80
Download
About
NOTES:
A case is defined as a child with a blood lead concentration ≥0.24 μmol/L (equivalent to ≥5 μg/dL) detected in a UK Accreditation Service (UKAS) accredited biochemistry or toxicology laboratory. This is reported to UKHSA for public health intervention. The child is aged under 16 years at the time elevated levels of lead are detected in the blood and resident of England.
Prior to 5 July 2021, the case definition for surveillance was 0.48 μmol/L (equivalent to ≥10μg/dL).
Since 5 July 2021, the case definition for surveillance changed to half the original concentration to 0.24μmol/L (equivalent to ≥5μg/dL). As expected, this led to a steep increase in the number of cases being reported to LEICSS.
The percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Cases by deprivation, 2015 to 2023 data for the percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Up to and including 31 December 2024
Deprivation quintile
Percent of cases
1
4.00
2
11.00
3
14.00
4
20.00
5
51.00
Download
Cases by deprivation, 2024
The percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.
Cases by deprivation, 2024 data for the percentage of LEICSS cases by quintile of the Index of Multiple Deprivation (IMD), highlighting case distribution across severity of deprivation index quintile. Quintile 1 represents the least deprived regions while quintile 5 represents the most deprived regions.